Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers

Launched by GORDON SCHANZLIN NEW VISION · Dec 18, 2023

Keywords

ClinConnect Summary

The study design is a single center, open label, double arm study with no control and no randomization. We will enroll 50 patients who are adjusted contact lens wearers who have corrected visual acuity of 20/25 or better at distance. 25 patients will be in daily disposable contact lens of varied manufacturers. The other 25 will be in monthly disposable contact lenses of varied manufacturers. Subjects will insert the Miebo eye drops four times a day, and with their contact lenses removed every day. Subjects will be required to wait at least 30 minutes before inserting their lenses after drop...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female, aged ≥ 18 years of age
• • Habitual contact lens wear for ≥ 60 days
• • Willing to sign the informed consent form and is deemed capable of complying with the requirements of the study protocol.
• Exclusion Criteria:
• • Previous use or known allergy to Miebo
• • Subjects with corneal abnormality or eye pathology that would affect the outcome in the investigator's opinion.
• • Women of child-bearing potential, defined as all women physiologically capable of becoming pregnant, unless they are using basic methods of contraception during dosing of study treatment.